Sigilon Therapeutics (SGTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 95 252 sessions, August 18, 2022 to August 18, 2023
- Largest daily move
- +438.2% close of June 29, 2023
- 1-year change
- +159.9% closing prices, August 18, 2022 to August 18, 2023
Company Description
Sigilon Therapeutics (NASDAQ: SGTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $56.2M.
SGTX has gained 159.9% over the past year. The last closing price was $22.47.
This page collects what Stock Titan holds for SGTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sigilon Therapeutics (SGTX) closed at $22.47 on August 18, 2023. Over the past 12 months, the price has gained 159.9%.
SGTX Metrics & Rankings
Price returns through August 18, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Sigilon Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, stock split, earnings, conferences, management. View all SGTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SGTX Company Profile & Sector Positioning
Sigilon Therapeutics (SGTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SGTX often look at related companies in the same sector, including CAMP4 Therapeutics Corporation (CAMP), Cue Biopharma, Inc. (CUE), PDS Biotechnology Corporation (PDSB), Jupiter Neurosciences, Inc. (JUNS), and BioXcel Therapeutics, Inc. (BTAI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SGTX's relative position within its industry.